Malaria P.f/Pan Antigen Rapid Test

The Malaria P.f/Pan Antigen Rapid Test is a rapid lateral flow immunoassay for the qualitative detection of Histidine-Rich Protein II (HRP-II) specific to Plasmodium falciparum (P.f) and Plasmodium lactate dehydrogenase (pLDH) specific to Plasmodium species (Pan) in human whole blood specimen. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with Malaria.

For professional in vitro diagnostic use only.

The Malaria P.f/P.v Antigen Rapid Test is a lateral flow immunoassay for the qualitative detection of Histidine-Rich Protein II (HRP-II) specific to Plasmodium falciparum (P.f) and Plasmodium lactate dehydrogenase (pLDH) specific to Plasmodium vivax (P.v) in human whole blood specimen. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with Malaria. For professional in vitro diagnostic use only.

fT3 Rapid Quantitative Test

Thyroxine (T4) is the main thyroid hormone secreted into the bloodstream by the thyroid gland. Together with triiodothyronine (T3) it plays a vital role in regulating the body's metabolic rate, influences the cardiovascular system, growth and bone metabolism, and is important for normal development of gonadal functions and nervous system.

3 in 1 (cTnI/CK-MB/Myo) Rapid Quantitative Test

3 in 1 test kit has a very high specificity and sensitivity for the detection of AMI, making a correct and timely diagnosis for patients with chest pain or clinically suspected AMI, and thus providing validly basis for clinicians with prompt rescue and treatment.

D-Dimer Rapid Quantitative Test (Chemiluminescence Immunoassay)

D-Dimer Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the D-Dimer concentration in human sodium citrate anticoagulant-contained plasma (1:9) and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

hs cTnI Rapid Quantitative Test

cTnI, a crucial cardiac biomarker, assists in detecting and managing acute myocardial infarction and assessing patient risk in cardiovascular events. Biotime's hs-cTnI offers high sensitivity, compatibility with versatile samples, and stable performance. Trust our ideal biomarker for comprehensive acute coronary syndrome evaluation.

HCV Rapid Quantitative Test

Hepatitis C is a liver disease caused by the hepatitis C virus (HCV): the virus can cause both acute and chronic hepatitis, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness. Hepatitis C is a major cause of liver cancer.

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

Myo Rapid Quantitative Test (Chemiluminescence Immunoassay)

Myo Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the myoglobin (Myo) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood, mainly used for auxiliary diagnosis of cardiac diseases.